SEC Form 4 · accession 0001232524-15-000173
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Patrick Miller
Officer — SVP, US Commercial
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Dec 15, 2015 | S | 100 | $136.99 | D | 13,661 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Includes 71 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2015.